SLC7A3 is an arginine transporter, a recent study revealed that breast cancer patients with high SLC7A4 expression had better prognoses, while the role of SLC7A3 in breast cancer progression remains unclear [15-17]. This evidence concerns the gene SLC7A3 and breast carcinoma.